Namwiwat Medical Corporation PCL (BKK:NAM)
3.720
-0.060 (-1.59%)
At close: Mar 27, 2026
BKK:NAM Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 697.82 | 920.84 | 995.66 | 59.02 | 40.86 |
Short-Term Investments | 0.28 | 0.07 | - | - | - |
Trading Asset Securities | 0.67 | 59.87 | 102.91 | 300.59 | - |
Cash & Short-Term Investments | 698.78 | 980.78 | 1,099 | 359.6 | 40.86 |
Cash Growth | -28.75% | -10.72% | 205.49% | 780.09% | 43.47% |
Accounts Receivable | 616.17 | 561.43 | 336.46 | 464.27 | 229.78 |
Other Receivables | 50.81 | 34.58 | 31.56 | 15.04 | - |
Receivables | 666.98 | 596.01 | 368.02 | 479.31 | 229.78 |
Inventory | 840.11 | 484.35 | 370.74 | 385.87 | 388.08 |
Prepaid Expenses | 14.99 | 17.61 | 9.36 | 3.68 | - |
Other Current Assets | 1.63 | 0.75 | 2.12 | 2.43 | - |
Total Current Assets | 2,222 | 2,080 | 1,849 | 1,231 | 658.72 |
Property, Plant & Equipment | 588.96 | 463.54 | 395.05 | 390.02 | 367.32 |
Long-Term Investments | - | - | - | 10 | 2.98 |
Goodwill | 63.99 | 17.95 | - | - | - |
Other Intangible Assets | 25.97 | 28.03 | 23.44 | 18.9 | 1.91 |
Long-Term Accounts Receivable | 7.35 | 13.77 | - | - | - |
Long-Term Deferred Tax Assets | 14.67 | 5.09 | 4.86 | 3.43 | 6.41 |
Long-Term Deferred Charges | 73.12 | 57.09 | 40.55 | 37.16 | - |
Other Long-Term Assets | 55.42 | 44.08 | 36.97 | 6.95 | 11.8 |
Total Assets | 3,052 | 2,709 | 2,350 | 1,697 | 1,049 |
Accounts Payable | 283.19 | 104.18 | 36.63 | 53.74 | 63.56 |
Accrued Expenses | 58.86 | 43.55 | 36.25 | 16.11 | 27.44 |
Short-Term Debt | 307.45 | 277.27 | 119.06 | 118.71 | 234.41 |
Current Portion of Long-Term Debt | 29 | 9.06 | 23.84 | 33.29 | - |
Current Portion of Leases | 22.79 | 8.1 | 6.82 | 4.85 | 5.28 |
Current Income Taxes Payable | 17.33 | 28.17 | 19.42 | 44.33 | 28.09 |
Current Unearned Revenue | 30.29 | 25.16 | 10.58 | 31.55 | 39.52 |
Other Current Liabilities | 6.64 | 11.5 | 8.04 | 42.44 | 49.35 |
Total Current Liabilities | 755.55 | 506.99 | 260.63 | 345.03 | 447.65 |
Long-Term Debt | 88.67 | 34.36 | 74.68 | 96.68 | 124.62 |
Long-Term Leases | 47.4 | 21.01 | 6.95 | 9.73 | 10.58 |
Long-Term Unearned Revenue | 8.29 | 10.52 | 17.04 | 11.23 | 9.55 |
Pension & Post-Retirement Benefits | 47.02 | 38.15 | 26.62 | 23.26 | 28.13 |
Long-Term Deferred Tax Liabilities | 1.83 | 1.59 | - | - | - |
Other Long-Term Liabilities | 0.64 | 1 | 1.01 | 1.11 | 0.91 |
Total Liabilities | 949.4 | 613.62 | 386.93 | 487.03 | 621.44 |
Common Stock | 350 | 350 | 350 | 297.5 | 10 |
Additional Paid-In Capital | 1,460 | 1,460 | 1,460 | 728.14 | - |
Retained Earnings | 189.86 | 261.5 | 153.03 | 184.66 | 424.12 |
Total Common Equity | 2,000 | 2,071 | 1,963 | 1,210 | 434.12 |
Minority Interest | 102.99 | 24.21 | 0 | - | -6.41 |
Shareholders' Equity | 2,103 | 2,095 | 1,963 | 1,210 | 427.71 |
Total Liabilities & Equity | 3,052 | 2,709 | 2,350 | 1,697 | 1,049 |
Total Debt | 495.31 | 349.8 | 231.35 | 263.27 | 374.89 |
Net Cash (Debt) | 203.47 | 630.98 | 867.22 | 96.34 | -334.03 |
Net Cash Growth | -67.75% | -27.24% | 800.18% | - | - |
Net Cash Per Share | 0.29 | 0.90 | 1.41 | 3.66 | -16.70 |
Filing Date Shares Outstanding | 700 | 700 | 700 | 595 | 20 |
Total Common Shares Outstanding | 700 | 700 | 700 | 595 | 20 |
Working Capital | 1,467 | 1,573 | 1,588 | 885.85 | 211.07 |
Book Value Per Share | 2.86 | 2.96 | 2.80 | 2.03 | 21.71 |
Tangible Book Value | 1,910 | 2,025 | 1,939 | 1,191 | 432.21 |
Tangible Book Value Per Share | 2.73 | 2.89 | 2.77 | 2.00 | 21.61 |
Land | 252.65 | 236.81 | 223.78 | 212.72 | - |
Buildings | 172.13 | 138.6 | 104.89 | 98.54 | - |
Machinery | 383.94 | 220.42 | 175.84 | 173.58 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.